Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000535

Drug Information
NameIboctadekin + Doxil
CompanyGSK
IndicationOvarian cancer
[ICD9: 183   ICD10: C56]
Phase I    
TargetInterleukin-18Modulator[1]
Interleukin-18Multitarget[1]
Topoisomerase IIInhibitor[1]
Topoisomerase IIMultitarget[1]
Ref 1GSK. Product Development Pipeline. February 2009. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543